本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Neurosense Therapeutics Ltd

1.00
+0.01311.32%
盤後1.010.0100+1.00%17:23 EDT
成交量:11.86萬
成交額:11.83萬
市值:2,398.87萬
市盈率:-1.82
高:1.02
開:1.02
低:0.9600
收:0.9869
資料載入中...
2025/04/07

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/01/16

SEC問詢函

Form CORRESP - Correspondence
2025/01/06

SEC問詢函

Form CORRESP - Correspondence
2024/12/13

SEC問詢函

Form CORRESP - Correspondence
2024/12/09

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/22

SEC問詢函

Form CORRESP - Correspondence
2024/11/19

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/05/21

SEC問詢函

Form CORRESP - Correspondence
2024/05/20

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2024/05/10

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/04/04

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/12/04

SEC問詢函

Form CORRESP - Correspondence
2023/09/01

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/31

SEC問詢函

Form CORRESP - Correspondence
2023/08/15

[修訂]招股説明書

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/08/14

SEC問詢函

Form CORRESP - Correspondence
2023/07/21

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2023/04/05

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals